Perceptions of The Health Risks of Cosmetics, and What it means to Their Regulation

Why Should You Attend:

Nowhere in the world today do we have a united assessment of the risk proposed by cosmetics. There are often completely opposing views from consumers, scientists, NGOs, regulators and the companies who develop and market these products. Cosmetic labels scream of all of the nasty chemicals they do not contain. But who says they are nasty? Where’s the proof?

Furthermore, the regulation of cosmetics is often thought as “regulation light”, and a subject not taken seriously. Cosmetic regulations today are complex and becoming more so. Even more importantly, cosmetic science is spectacularly advanced and now borders on drug and medical device science.

Exacerbating the situation is that there is no harmonized global approach to regulation. Drugs and medical devices have, by comparison, far more consistent approaches, and receive a great deal of assistance from regulators in granting approvals. In many global markets, cosmetics simply arrive on store shelves and often the first intersection with a regulator is with a warning capable of threatening a company’s business.

This webinar will speak to some of the major issues in the science and regulation of cosmetics. While the focus will be on North America, there will be a general discussion on what regulatory framework this category deserves. What are the challenges facing the industry and regulators? Where is the line between cosmetics and drugs? How do we deal with the exciting and challenging innovations such as cosmetic active ingredients, medical devices and nutritional supplements for beauty? And finally, just how risky are today’s cosmetic products?

Learning Objectives:

From the seminar you will learn:

• The competing views of cosmetic risk
• How regulators regulate cosmetics compared to other categories
• The key issues regulating cosmetics
• The very fine line between cosmetics and drugs
• The roles of organizations influencing cosmetic regulations
• Future directions for cosmetic regulations

Areas Covered in the Webinar:

• Competing views of the risk of cosmetics
• Current approaches to the regulation of Cosmetics
• Issues with Cosmetic Regulation
• Organizations influencing regulations: governments, industry, NGOs
• Future predictions for Cosmetic Regulation
• How much risk do cosmetics pose?

Who Will Benefit:

• Regulatory affairs
• Research and Development
• Marketing personnel
• Manufacturers
• Brand owners
• Importers and Distributors

Rob Ross Fichtner
President and CEO, Focal Point Research Inc

Rob Ross-Fichtner (President & CEO Focal Point Research Inc., Professor at Seneca College) has more than 35 years of experience in the formulation, manufacturing and regulation of cosmetics, drugs, medical devices and nutritional supplements. He has completed hundreds of regulatory submissions for product registration and approval, and has served as a consultant to companies of all sizes around the world pertaining to their Canadian and US compliance. He has also served as a consultant directly to Health Canada.

Rob has extensive experience inspecting Cosmetic and OTC drug facilities and developing QA programs in Canada, the US and in international locations. He also has many years of experience in Research and Development, including formulation, stability and analytical chemistry, clinical trials and manufacturing. He has served as an expert witness in litigation, and contributes regularly to the development of intellectual property.

Follow us :